This project will identify compounds that can improve the efficacy of clinically used chemotherapy, which should ultimately lead to an increase in the overall survival for those breast cancer patients receiving paclitaxel based therapies. Our hypothesis is that drugs that inhibit the recovery of breast cancer cells exposed to paclitaxel are ideally suited for maximizing the anti-cancer benefit of this chemotherapy.
Posting date: Fri, 09/23/2016
Award start date: Tue, 08/16/2016
Award end date: Wed, 07/31/2019
